Lv2
180 积分 2025-10-01 加入
Targeting AKT to treat liver disease: Opportunities and challenges
2个月前
已完结
Mechanisms and clinical significance of TGF-β in hepatocellular cancer progression
2个月前
已完结
Targeting AKT to treat liver disease: Opportunities and challenges
2个月前
已完结
Discovery and Optimization of 4-Aminopteridin-7(8H)-one Derivatives as Potent and Selective mTOR Inhibitors with Favorable Pharmacodynamic and Safety Characteristics
2个月前
已完结
Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade
2个月前
已完结
mTOR Inhibition Role in Cellular Mechanisms
2个月前
已完结
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
Pathophysiology of CLD: Oxidative Stress and Antioxidant Mechanisms that may Limit its Progression
2个月前
已完结
Hepatic inflammatory responses in liver fibrosis
2个月前
已完结
AKR1C3 promotes aerobic glycolysis in hepatic stellate cells via the AKT/mTOR pathway to induce liver fibrosis
2个月前
已完结
皖公网安备34019202002308
